Stay updated on Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.

Latest updates to the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2; removed the funding-status notice and the older Revision: v3.4.1 from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA government funding notice was added and the page revision tag updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedUI updates include a glossary toggle and the display of QC-related metadata (Last Update Submitted that Met QC Criteria) and the site revision version (v3.4.0); these changes affect presentation rather than core study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedA new Locations section has been added, listing California as a study site (Los Angeles, CA). The page's references to California Locations and the HHS Vulnerability Disclosure link were removed in revision 3.3.3.SummaryDifference0.2%

- Check92 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Efficacy of Rifaximin with NAC in IBS-D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Rifaximin with NAC in IBS-D Clinical Trial page.